ClinConnect ClinConnect Logo
Search / Trial NCT04663971

Fertility and Pregnancy After Surgery IBD Audit

Launched by UNIVERSITY OF CAMPANIA LUIGI VANVITELLI · Dec 5, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Crohn's Disease Ulcerative Colitis Surgery

ClinConnect Summary

This clinical trial, called the Fertility and Pregnancy After Surgery IBD Audit, is studying how conditions like Crohn's disease and Ulcerative colitis affect women's ability to have children and their experiences during pregnancy and delivery. These diseases often start when people are young, and the treatments for them can influence sexual function and fertility. The researchers want to understand these effects better, specifically in women who have had surgery for these conditions before turning 36 years old.

To participate in this study, women must be diagnosed with either Crohn's disease or Ulcerative colitis and have undergone surgery related to their condition. They should be between the ages of 18 and 36 at the time of follow-up. The trial is currently recruiting participants, and some women who have not had surgery will also be included for comparison. If you join the study, you can expect to share your experiences related to fertility and pregnancy, helping researchers learn how to better support women facing these challenges.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Crohn's disease diagnosis
  • ulcerative disease diagnosis
  • operated on before 36 years of age
  • Exclusion Criteria:
  • younger than 18 years old at follow-up
  • no definitive diagnosis
  • no surgical procedures performed
  • A subgroup of patients who did not undergo surgery will be used, at least one for each country.

About University Of Campania Luigi Vanvitelli

The University of Campania Luigi Vanvitelli is a distinguished academic institution located in Italy, renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in biomedical sciences to conduct innovative studies that address critical health challenges. With a focus on ethical standards and patient safety, the university collaborates with various healthcare professionals and research entities to facilitate groundbreaking clinical investigations, ultimately contributing to the development of new therapies and enhancing medical knowledge.

Locations

Bologna, , Italy

Roma, , Italy

Milano, , Italy

Napoli, , Italy

Patients applied

0 patients applied

Trial Officials

Giuseppe Sica, MD, PhD

Study Chair

University Tor Vergata Roma

Matteo Rottoli, MD, PhD

Study Chair

University Alma Mater Bologna

Francesco Selvaggi, MD, PhD

Study Chair

University of Campania Luigi Vanvitelli Napoli

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials